Supported by National Natural Science Fund of China (No.81130062, 81403367);the National Key Technology R&D Program during the 12th Five-Year Plan Period(2014BAI10B06)。
OBJECTIVE: To study the mechanistic effects of Tiaobu Feishen therapy(TBFS) on inflammation induced by cigarette smoke extract(CSE) in a human monocyte/macrophage cell line.METHODS: The human monocyte/macrophage cell ...
supported by the National Natural Science Fundation of China(No.81973822,81130062,81603473);National Public Welfare Industry Research Project-Traditional Chinese Medicine Industry(No.201507001-01);National Key Research and Development Program of China(No.2018YFC1704806)。
Objective:Critical effective constituents were identified from Bufei Yishen formula(BYF),a traditional herbal compound and combined as effective-constituent compatibility(ECC)of BYF I,which may have potential bioactiv...
Supported by National Natural Science Fund of China(No.81130062,81603473,81403367);Outstanding Traditional Chinese Medicine Academic Leader Program of Henan Province(No.HNZYLJ201301001);the National Key Technology R&D Program during the 12th Five-Year Plan Period(No.2014BAI10B06)。
OBJECTIVE: To investigate the therapeutic efficacy of Tiaobu Feishen formulae(TBFS) on cigarette smoke-induced inflammation in vitro using lipopolysaccharide(LPS)-induced and cigarette smoke extract(CSE)-induced NCI-H...
National Natural Science Fund of China(No.81130062,No.81403367);Outstanding Traditional Chinese Medicine Academic Leader Program of Henan Province(No.HNZYLJ201301001);the National Key Technology R&D Program during the 12th Five-Year Plan Period(No.2014BAI10B06)
OBJECTIVE: To investigate the efficacy of Tiaobu Feishen formulae(TBFS), including Bufei Jianpi formula(BJF), Bufei Yishen formula(BYF), and Yiqi Zishen formula(YZF), on inflammatory response, protease-anti-protease i...